Stocks
CASI Pharmaceuticals IncCASI
NASDAQHealthcareBiotechnology$0.21
Focused on developing and commercializing oncology therapeutics, the company in-licenses, develops, and markets cancer treatments primarily for the China market. Its portfolio includes approved and pipeline drugs targeting hematologic malignancies and other cancers, often sourced through partnership...
52W Range: $0.21 – $3.09
Congressional Interest in CASI Pharmaceuticals Inc (CASI)
No congressional trades have been disclosed for CASI Pharmaceuticals Inc (CASI) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading CASI?
No congressional trades found for this stock.